Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2026 ▲▼ | Q2 2026 ▲▼ | Change ▲▼ | Q1 2026 ▲▼ | Q2 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Praxis Precision Medicines, Inc.(PRAX) | 100,781 | 88,781 | -12,000 | $32.47M | $29.72M | 18.21% | -$2.75M |
| MapLight Therapeutics, Inc.(MPLT) | 492,893 | 492,893 | 0 | $10.02M | $17.67M | 10.82% | +$7.64M |
| Sutro Biopharma, Inc.(STRO) | 512,160 | 512,160 | 0 | $12.76M | $17.00M | 10.42% | +$4.25M |
| Immix Biopharma, Inc.(IMMX) | 740,000 | 1,085,000 | +345,000 | $6.74M | $11.19M | 6.85% | +$4.44M |
| Protara Therapeutics, Inc.(TARA) | 2,834,652 | 2,844,652 | +10,000 | $14.77M | $10.87M | 6.66% | -$3.90M |
| ABIVAX Société AnonymeADS(ABVX) | 77,000 | 65,630 | -11,370 | $8.57M | $8.75M | 5.36% | +$171.9K |
| Tenax Therapeutics, Inc.(TENX) | 583,333 | 549,985 | -33,348 | $9.33M | $8.00M | 4.90% | -$1.33M |
| Anteris Technologies Global Corp.(AVR) | 700,000 | 700,000 | 0 | $3.88M | $6.89M | 4.22% | +$3.01M |
| Edesa Biotech, Inc.(EDSA) | 827,500 | 827,500 | 0 | $4.33M | $6.73M | 4.12% | +$2.40M |
| Evommune, Inc.(EVMN) | 446,255 | 451,255 | +5,000 | $10.26M | $6.00M | 3.67% | -$4.26M |
| Avalo Therapeutics, Inc.(AVTX) | 185,122 | 324,452 | +139,330 | $2.76M | $6.00M | 3.67% | +$3.23M |
| Xencor, Inc.(XNCR) | 250,000 | 255,000 | +5,000 | $3.02M | $4.11M | 2.52% | +$1.09M |
| Rezolute, Inc.(RZLT) | 750,000 | 750,000 | 0 | $2.29M | $3.90M | 2.39% | +$1.61M |
| Heron Therapeutics, Inc.(HRTX) | 8,753,290 | 8,753,290 | 0 | $7.00M | $3.74M | 2.29% | -$3.27M |
| Verrica Pharmaceuticals Inc.(VRCA) | 471,559 | 471,559 | 0 | $2.49M | $2.89M | 1.77% | +$391.4K |
| C4 Therapeutics, Inc.(CCCC) | 0 | 570,000 | +570,000 | $0 | $2.66M | 1.63% | +$2.66M |
| Eupraxia Pharmaceuticals Inc.(EPRX) | 352,000 | 352,000 | 0 | $2.55M | $2.33M | 1.43% | -$221.8K |
| Adma Biologics Inc | 0 | 250,000 | +250,000 | $0 | $2.09M | 1.28% | +$2.09M |
| Rein Therapeutics Inc.(RNTX) | 0 | 1,700,000 | +1,700,000 | $0 | $1.77M | 1.08% | +$1.77M |
| Lyell Immunopharma, Inc.(LYEL) | 102,000 | 105,000 | +3,000 | $2.05M | $1.48M | 0.90% | -$570.9K |
| Nasus Pharma Ltd.(NSRX) | 359,390 | 359,390 | 0 | $797.8K | $1.26M | 0.77% | +$460.0K |
| Profound Medical Corp.(PROF) | 285,710 | 170,278 | -115,432 | $1.85M | $1.13M | 0.69% | -$719.1K |
| Jasper Therapeutics, Inc.(JSPR) | 2,668,395 | 2,668,395 | 0 | $2.34M | $1.12M | 0.69% | -$1.21M |
| Protagonist Therapeutics Inc | 3,700 | 3,700 | 0 | $390.0K | $453.5K | 0.28% | +$63.6K |
| CytomX Therapeutics, Inc.(CTMX) | 540,000 | 120,000 | -420,000 | $2.54M | $450.0K | 0.28% | -$2.09M |
| Neumora Therapeutics, Inc.(NMRA) | 80,000 | 230,000 | +150,000 | $156.0K | $391.0K | 0.24% | +$235.0K |
| Nurix Therapeutics, Inc.(NRIX) | 16,000 | 16,000 | 0 | $248.0K | $388.2K | 0.24% | +$140.2K |
| Ovid Therapeutics Inc.(OVID) | 160,000 | 130,000 | -30,000 | $355.2K | $349.7K | 0.21% | -$5.5K |
| Precision BioSciences, Inc.(DTIL) | 40,000 | 40,000 | 0 | $220.0K | $314.4K | 0.19% | +$94.4K |
| Mineralys Therapeutics, Inc.(MLYS) | 11,000 | 11,000 | 0 | $298.0K | $296.8K | 0.18% | -$1.2K |
| MacroGenics, Inc.(MGNX) | 30,000 | 60,000 | +30,000 | $86.7K | $277.2K | 0.17% | +$190.5K |
| Corbus Pharmaceuticals Holdings, Inc.(CRBP) | 26,000 | 26,000 | 0 | $244.1K | $243.9K | 0.15% | -$260 |
| Artiva Biotherapeutics, Inc.(ARTV) | 25,000 | 25,000 | 0 | $161.0K | $242.5K | 0.15% | +$81.5K |
| Replimune Group, Inc.(REPL) | 20,000 | 20,000 | 0 | $153.0K | $221.4K | 0.14% | +$68.4K |
| Syndax Pharmaceuticals, Inc.(SNDX) | 10,000 | 10,000 | 0 | $233.6K | $218.6K | 0.13% | -$15.0K |
| Immunome, Inc.(IMNM) | 10,000 | 10,000 | 0 | $218.7K | $211.9K | 0.13% | -$6.8K |
| Tectonic Therapeutic, Inc.(TECX) | 0 | 6,000 | +6,000 | $0 | $206.3K | 0.13% | +$206.3K |
| Rocket Pharmaceuticals, Inc.(RCKT) | 294,643 | 60,000 | -234,643 | $1.05M | $205.2K | 0.13% | -$849.6K |
| Karyopharm Therapeutics Inc.(KPTI) | 15,000 | 20,000 | +5,000 | $83.5K | $195.4K | 0.12% | +$111.8K |
| An2 Therapeutics Inc | 0 | 40,000 | +40,000 | $0 | $193.6K | 0.12% | +$193.6K |
| Viridian Therapeutics, Inc.(VRDN) | 91,123 | 10,000 | -81,123 | $1.78M | $183.7K | 0.11% | -$1.60M |
| Scynexis Inc | 0 | 40,000 | +40,000 | $0 | $162.8K | 0.10% | +$162.8K |
| Quoin Pharmaceuticals, Ltd.ADS(QNRX) | 84,849 | 32,372 | -52,477 | $560.0K | $156.7K | 0.10% | -$403.3K |
| Xilio Therapeutics, Inc.(XLO) | 14,285 | 14,285 | 0 | $120.1K | $136.8K | 0.08% | +$16.7K |
| InspireMD, Inc.(NSPR) | 2,099,652 | 148,138 | -1,951,514 | $3.42M | $103.7K | 0.06% | -$3.32M |
| Kalaris Therapeutics, Inc.(KLRS) | 18,000 | 25,000 | +7,000 | $103.9K | $101.8K | 0.06% | -$2.1K |
| Larimar Therapeutics, Inc.(LRMR) | 33,000 | 33,000 | 0 | $148.5K | $100.7K | 0.06% | -$47.9K |
| Proqr Thrapeutics N VSHS EURO SHS EURO | 45,000 | 45,000 | 0 | $72.9K | $83.7K | 0.05% | +$10.8K |
| Context Therapeutics Inc.(CNTX) | 100,000 | 59,700 | -40,300 | $262.0K | $33.1K | 0.02% | -$228.9K |
| Gossamer Bio, Inc.(GOSS) | 70,000 | 70,000 | 0 | $23.0K | $11.5K | 0.01% | -$11.5K |
| Arrowhead Pharmaceuticals, Inc.(ARWR) | 6,500 | 0 | -6,500 | $407.6K | $0 | — | -$407.6K |
| Design Therapeutics, Inc.(DSGN) | 20,000 | 0 | -20,000 | $212.8K | $0 | — | -$212.8K |
| Esperion Therapeutics Inc Ne | 1,720,000 | 0 | -1,720,000 | $4.71M | $0 | — | -$4.71M |
| Kazia Therapeutics LimitedADS(KZIA) | 135,315 | 0 | -135,315 | $1.01M | $0 | — | -$1.01M |
| PMV Pharmaceuticals, Inc.(PMVP) | 73,000 | 0 | -73,000 | $90.5K | $0 | — | -$90.5K |